Resistance to neoadjuvant talazoparib in triple-negative breast cancer by BRN2-induced ATR/STAT3 pathways or SHLD2 subclone expansion - Noor M. Abdulkareem; Yan Jiang; Yuan Qi; Xuan Liu; Xiaomei Zhang; Shirong Cai; Jiansu Shao; Sabrina Jeter-Jones; Amanda L. Rinkenbaugh; Chun-Chun Cheng; Faiza Hancock; Jill Schwartz; et al. (Proceedings of the National Academy of Sciences, 2026)